Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated After Chemoradiotherapy and an 8-Year Update on a Phase I/Ii Trial

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-11-1385
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

P3.17-12 Phase II Trial of Atezolizumab Before and After Chemoradiation for Unresectable Stage III NSCLC (AFT-16): Trial in Progress

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

OA01.07 Updated Results of a Phase II Trial of Concurrent Chemoradiation With Consolidation Pembrolizumab in Patients With Unresectable Stage III NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Mitomycin C and Vinorelbine for Second-Line Chemotherapy in NSCLC – A Phase II Trial

British Journal of Cancer
Cancer ResearchOncology
2007English

Phase II Trial of SBRT for Stage I NSCLC: Survival, Local Control, and Lung Function at 36 Months

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

MA05.07 Dose Escalated Chemo-Rt to 84 Gy in Stage III NSCLC Appears Excessively Toxic: Results From a Randomized Phase II Trial

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Randomized Phase II Trial of Survivin 2B Peptide Vaccination for Patients With HLA-A24-positive Pancreatic Adenocarcinoma

Cancer Science
Cancer ResearchMedicineOncology
2019English

Brief Report: Three-Year Overall Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC - Update From PACIFIC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2020English

Tn-Muc1 DC Vaccination of Rhesus Macaques and a Phase I/Ii Trial in Patients With Nonmetastatic Castrate-Resistant Prostate Cancer

Cancer immunology research
Cancer ResearchImmunology
2016English

Randomized Phase III Trial Comparing Surgery Alone to UFT + PSK for Stage II Rectal Cancer (JFMC38 Trial)

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy